Radcliffe Capital Management »

Aeon Biopharma I shares owned by Radcliffe Capital Management

Quarter-by-quarter ownership of Aeon Biopharma I (AEON.WS) shares owned by Radcliffe Capital Management from 13F filings

Historical chart of Radcliffe Capital Management investment in Aeon Biopharma I

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma I held by Radcliffe Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma I by Radcliffe Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $43k 268k 0.16

More positions owned by Radcliffe Capital Management

Alteryx Conv (Principal)
Spotify Technology Conv (Principal)
Magnite Conv (Principal)
Alteryx Conv (Principal)
Compass Digital Acquisition Corp Common Stock (CDAQ)
DocuSign Conv (Principal)
Prospect Capital Corp Conv (Principal)
Ares Acquisition Corp Common Stock
Churchill Capital Corp VII Common Stock (CVII)
Ares Acquisition Corp II Common Stock (AACT)
Apollo Strategic Growth Capital II Common Stock
Globus Medical Conv (Principal)
Screaming Eagle Acquisition Corp Common Stock (SCRM)
Enphys Acquisition Corp Common Stock (NFYS)
CF Acquisition Corp IV Common Stock

View all positions for Radcliffe Capital Management

Top funds holding Aeon Biopharma I

Cantor Fitzgerald, L. P.
Davidson Kempner Capital Management
Aristeia Capital
LMR Partners
Tenor Capital Management
D. E. Shaw & Co
Millennium Management
Hudson Bay Capital Management
Whitebox Advisors
Wolverine Asset Management
Kim
Calamos Advisors
Goldman Sachs Group
Sandia Investment Management
Walleye Trading Advisors

View all funds holding Aeon Biopharma I